Nephros, Inc.
NEPH
$2.90
$0.124.32%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 18.79M | 17.93M | 16.68M | 15.52M | 14.16M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 18.79M | 17.93M | 16.68M | 15.52M | 14.16M |
| Cost of Revenue | 7.16M | 6.59M | 6.11M | 5.83M | 5.44M |
| Gross Profit | 11.63M | 11.34M | 10.57M | 9.69M | 8.72M |
| SG&A Expenses | 9.00M | 8.56M | 8.05M | 7.79M | 7.68M |
| Depreciation & Amortization | 140.00K | 142.00K | 142.00K | 141.00K | 135.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 17.64M | 16.49M | 15.35M | 14.75M | 14.16M |
| Operating Income | 1.15M | 1.45M | 1.34M | 772.00K | 6.00K |
| Income Before Tax | 1.21M | 1.51M | 1.35M | 816.00K | 89.00K |
| Income Tax Expenses | 12.00K | 27.00K | 24.00K | 15.00K | 15.00K |
| Earnings from Continuing Operations | 1.19 | 1.48 | 1.33 | 0.80 | 0.07 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.19M | 1.48M | 1.33M | 801.00K | 74.00K |
| EBIT | 1.15M | 1.45M | 1.34M | 772.00K | 6.00K |
| EBITDA | 1.29M | 1.59M | 1.48M | 915.00K | 143.00K |
| EPS Basic | 0.11 | 0.14 | 0.13 | 0.08 | 0.01 |
| Normalized Basic EPS | 0.07 | 0.09 | 0.08 | 0.05 | 0.01 |
| EPS Diluted | 0.11 | 0.13 | 0.12 | 0.07 | 0.00 |
| Normalized Diluted EPS | 0.07 | 0.09 | 0.08 | 0.05 | 0.01 |
| Average Basic Shares Outstanding | 42.46M | 42.36M | 42.29M | 42.19M | 42.10M |
| Average Diluted Shares Outstanding | 43.68M | 43.03M | 42.57M | 42.26M | 42.15M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |